Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Refining the Definition of Polypharmacy and Its Link to Disability in Older Adults: Conceptualizing Necessary Polypharmacy, Unnecessary Polypharmacy, and Polypharmacy of Unclear Benefit.
Lee EA, Brettler JW, Kanter MH, Steinberg SG, Khang P, Distasio CC, Martin J, Dreskin M, Thompson NH, Cotter TM, Thai K, Yasumura L, Gibbs NE. Lee EA, et al. Among authors: brettler jw. Perm J. 2020;24:18.212. doi: 10.7812/TPP/18.212. Epub 2019 Dec 11. Perm J. 2020. PMID: 31905333 Free PMC article.
Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID-19 Infection Among 824 650 Patients With Hypertension From a US Integrated Healthcare System.
An J, Wei R, Zhou H, Luong TQ, Gould MK, Mefford MT, Harrison TN, Creekmur B, Lee MS, Sim JJ, Brettler JW, Martin JP, Ong-Su AL, Reynolds K. An J, et al. Among authors: brettler jw. J Am Heart Assoc. 2021 Feb 2;10(3):e019669. doi: 10.1161/JAHA.120.019669. Epub 2020 Dec 14. J Am Heart Assoc. 2021. PMID: 33307964 Free PMC article.
COVID-19 morbidity and mortality associated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers use among 14,129 patients with hypertension from a US integrated healthcare system.
An J, Zhou H, Wei R, Luong TQ, Gould MK, Mefford MT, Harrison TN, Creekmur B, Lee MS, Sim JJ, Brettler JW, Martin JP, Ong-Su AL, Reynolds K. An J, et al. Among authors: brettler jw. Int J Cardiol Hypertens. 2021 Jun;9:100088. doi: 10.1016/j.ijchy.2021.100088. Epub 2021 Jun 15. Int J Cardiol Hypertens. 2021. PMID: 34155486 Free PMC article.
Risk of hospitalization and mortality associated with uncontrolled blood pressure in patients with hypertension and COVID-19.
An J, Zhou H, Luong TQ, Wei R, Mefford MT, Harrison TN, Lee MS, Sim JJ, Brettler JW, Martin JP, Ong-Su AL, Reynolds K. An J, et al. Among authors: brettler jw. Int J Cardiol Cardiovasc Risk Prev. 2021 Dec;11:200117. doi: 10.1016/j.ijcrp.2021.200117. Epub 2021 Nov 9. Int J Cardiol Cardiovasc Risk Prev. 2021. PMID: 34778888 Free PMC article.
Laboratory monitoring to reduce adverse drug-related events: a mixed methods study.
Harrison TN, Reynolds K, Hahn EE, Munoz-Plaza CE, Yi DK, Fischer H, Luong TQ, Sim JJ, Brettler J, Handler J, Mittman BS, Singh H, Kanter MH, Danforth KN. Harrison TN, et al. J Manag Care Spec Pharm. 2022 Jan;28(1):16-25. doi: 10.18553/jmcp.2022.28.1.16. J Manag Care Spec Pharm. 2022. PMID: 34949121 Free PMC article.
27 results